IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Marksans Pharma LTD INR 1.0

Q1 2018 vs Q2 2018

Comparing institutional holders between quarters

Quarters

Q2 2018Q1 2018Q4 2017
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Stanley-Laman Group, Ltd.
UNCHANGED
Shares599,100 from 599,100
Change0 (0%)
Value$230 (-$61)
Filed 2018-08-09
Status
Stanley-Laman Group, Ltd.
UNCHANGED599,100599,10000%$291$230-$612018-08-09
Showing 1 of 1 institutions